Versant Capital Management’s Genmab GMAB Stock Holding History
Bought
Maintained
Sold
Other funds holding GMAB
DGM
Versant Capital Management's GMAB Position: Q3 2026 in Review
Versant Capital Management increased its Genmab (GMAB) stake by 4.5% in Q3 2026, buying an estimated $16.5K and bringing the position to 12,235 shares worth $436K. The position accounts for 0.04% of the portfolio, ranked #357.
Versant Capital Management first reported a position in GMAB in Q1 2023 and has held it in 11 quarters since. 331 funds tracked by Wall St. Rank hold GMAB as of Q3 2026.
- Versant Capital Management held 12,235 shares of Genmab worth $436K as of Q3 2026.
- Versant Capital Management bought 523 Genmab shares in Q3 2026, an estimated $16.5K.
- Genmab made up 0.04% of Versant Capital Management's portfolio in Q3 2026, its #357 holding.
- Versant Capital Management first reported a position in Genmab in Q1 2023 and has held it in 11 quarters since.
- 331 funds tracked by Wall St. Rank held Genmab as of Q3 2026.
Based on Versant Capital Management's 13F filing for Q3 2026, filed 2 Oct 2026.